ExactVu for Prostate Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Prostate CancerExactVu - Device
Eligibility
18 - 89
Male
What conditions do you have?
Select

Study Summary

This trial uses ultrasound to image the prostate before biopsy or surgery. The images will be used to develop better tools.

Eligible Conditions
  • Prostate Cancer

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 8 Secondary · Reporting Duration: From date of micro ultrasound exam until the date of Prostate biopsy data are obtained (average of 7 days

Day 7
Diagnostic accuracy of micro-ultrasound biopsy and prostatectomy patients.
Location from systematic and targeted cores
Measuring correlation between Prostatectomy pathology and imaging correlation
Morphology of lesions detected by mirco-resolution ultrasound
Negative predictive values of high-resolution ultrasound and multiparametric MRI
Positive predictive values of high-resolution ultrasound and multiparametric
Sensitivity of micro-ultrasound and multiparametric MRI
Specificity of micro-ultrasound and multiparametric MRI
Volume from systematic and targeted cores

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

ExactVu Imaging
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: ExactVu · No Placebo Group · N/A

ExactVu Imaging
Device
Experimental Group · 1 Intervention: ExactVu · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from date of micro ultrasound exam until the date of prostate biopsy data are obtained (average of 7 days

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,168 Previous Clinical Trials
35,768,598 Total Patients Enrolled
22 Trials studying Prostate Cancer
3,890 Patients Enrolled for Prostate Cancer
Geoffrey SonnPrincipal InvestigatorStanford Universiy

Eligibility Criteria

Age 18 - 89 · Male Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are scheduled for MR-US fusion prostate biopsy or radical prostatectomy.